Infectious Bronchitis Virus (Beaudette (Massachusetts)) Allantoic Fluid

The Gamma-coronavirus known as Infectious bronchitis virus (IBV) from the Coronaviridae family leads to infectious bronchitis in chickens. Since its discovery in 1931 the virus presents a worldwide danger to poultry production through respiratory problems and kidney damage which causes decreased egg output as well as significant economic damage. The virus genome consists of single-stranded positive-sense RNA of about 27.6 kilobases which contains coding information for replicase polyproteins together with four structural proteins named S, E, M, and N. High mutation rates and recombination drive its genetic diversity.

Figure 1. Classification of infectious bronchitis virus (IBV) strains
(Source: Abozeid H. 2023)

The IBV virion is about 120 nm in diameter with surface spike (S) protein trimers that attach to the envelope and consist of S1 and S2 subunits. The S1 subunit includes the receptor-binding domain (RBD) and regions where neutralizing antibodies bind but serotype specificity and host range depend on hypervariable regions (HVRs) and the S2 subunit drives membrane fusion. Viral assembly occurs through M protein function which also induces interferon production; E protein drives budding processes and N protein attaches to viral RNA to build a nucleocapsid while preventing host type I interferon responses. The IBV genome (~27.6 kb) encodes the replicase complex (ORF1a/b) at its 5' end and accessory proteins (3a, 3b) at the 3' end, relying on nested mRNA transcription for gene expression.

IBV causes multisystemic disease in chickens, with symptoms varying by strain, host age, and immunity. Traditional vaccines (e.g., live-attenuated H120/4/91 and inactivated vaccines) provide serotype-specific protection but limited cross-reactivity. Emerging QX-like strains and vaccine-wild strain recombination exacerbate immune evasion. Novel strategies include DNA vaccines (targeting S1/M/N epitopes), plant-expressed S1 subunit vaccines, and inactivated vaccine boosters to enhance antibody titers and reduce viral loads. Persistent viral evolution demands focus on broad-spectrum vaccines (conserved epitope-based), host immune modulation (e.g., baicalin's STAT1-mediated antiviral effects), and global strain surveillance. Integrating molecular epidemiology and reverse genetics will clarify virulence determinants and cross-species risks, guiding sustainable control strategies.

IBV (Beaudette (Massachusetts)) Allantoic Fluid